Is Intraperitoneal Chemotherapy Dead?

Obstet Gynecol. 2016 Jun;127(6):983-984. doi: 10.1097/AOG.0000000000001461.

Authors

Angeles Alvarez Secord¹, Laura J Havrilesky

Affiliation

¹ Drs. Secord and Havrilesky are from the Division of Gynecology Oncology, Department of Obstetrics and Gynecology, at the Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; e-mail: secor002@mc.duke.edu and laura.havrilesky@duke.edu.

PMID: 27159765
DOI: 10.1097/AOG.0000000000001461

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Humans
Injections, Intraperitoneal*
Peritoneal Neoplasms*